C. Jarry

426 total citations
43 papers, 379 citations indexed

About

C. Jarry is a scholar working on Organic Chemistry, Spectroscopy and Molecular Biology. According to data from OpenAlex, C. Jarry has authored 43 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 13 papers in Spectroscopy and 12 papers in Molecular Biology. Recurrent topics in C. Jarry's work include Synthesis and Reactions of Organic Compounds (19 papers), Analytical Chemistry and Chromatography (13 papers) and Synthesis of heterocyclic compounds (9 papers). C. Jarry is often cited by papers focused on Synthesis and Reactions of Organic Compounds (19 papers), Analytical Chemistry and Chromatography (13 papers) and Synthesis of heterocyclic compounds (9 papers). C. Jarry collaborates with scholars based in France, Morocco and Belize. C. Jarry's co-authors include Fabienne Péhourcq, Myriam Matoga, B Bannwarth, Karine Titier, Isabelle Forfar, A. Carpy, Bernard Bégaud, M. LANGLOIS, E Panconi and J. P. Dubost and has published in prestigious journals such as Journal of Chromatography A, Tetrahedron and Journal of Pharmaceutical Sciences.

In The Last Decade

C. Jarry

42 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Jarry France 11 156 139 94 91 48 43 379
Myriam Matoga France 11 127 0.8× 36 0.3× 121 1.3× 113 1.2× 41 0.9× 18 380
G.S. Murkitt United Kingdom 9 109 0.7× 47 0.3× 84 0.9× 85 0.9× 35 0.7× 16 292
Tanja Alebić-Kolbah United States 14 216 1.4× 33 0.2× 82 0.9× 141 1.5× 94 2.0× 24 494
Károly Mazák Hungary 14 134 0.9× 96 0.7× 54 0.6× 149 1.6× 51 1.1× 33 396
Nafiz Öncü Can Türkiye 12 85 0.5× 193 1.4× 133 1.4× 98 1.1× 183 3.8× 46 512
A. Naidu India 12 107 0.7× 168 1.2× 156 1.7× 71 0.8× 104 2.2× 57 435
Bruce A. Lodge Canada 9 142 0.9× 53 0.4× 106 1.1× 68 0.7× 40 0.8× 55 320
Michael Chlenov United States 10 103 0.7× 64 0.5× 47 0.5× 85 0.9× 14 0.3× 21 263
Kapendra Sahu India 11 48 0.3× 180 1.3× 53 0.6× 104 1.1× 54 1.1× 37 398
Alison L. Fisher United States 13 121 0.8× 30 0.2× 134 1.4× 83 0.9× 84 1.8× 22 533

Countries citing papers authored by C. Jarry

Since Specialization
Citations

This map shows the geographic impact of C. Jarry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Jarry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Jarry more than expected).

Fields of papers citing papers by C. Jarry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Jarry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Jarry. The network helps show where C. Jarry may publish in the future.

Co-authorship network of co-authors of C. Jarry

This figure shows the co-authorship network connecting the top 25 collaborators of C. Jarry. A scholar is included among the top collaborators of C. Jarry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Jarry. C. Jarry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salem, Mohamed A., El Mokhtar Essassi, Saïd Lazar, et al.. (2008). Hydrazinolyse de la 2-Benzoyl-3-oxo-1,4-benzothiazine. Phosphorus, sulfur, and silicon and the related elements. 183(8). 1862–1869. 1 indexed citations
2.
Lazar, Saïd, Mustapha Soukri, Mohammadine El Haddad, et al.. (2004). Enantioselective synthesis of 2- and 3-substituted 2,3-dihydro[1,4]dioxino[2,3-b]pyridine derivatives and enantiomeric purity control by capillary electrophoresis. Chirality. 17(1). 30–36. 6 indexed citations
3.
Péhourcq, Fabienne, Myriam Matoga, C. Jarry, & B Bannwarth. (2003). HPLC microdetermination of flurbiprofen enantiomers in plasma with a glycopeptide‐type chiral stationary phase column. Biomedical Chromatography. 18(5). 330–334. 3 indexed citations
4.
Forfar, Isabelle, et al.. (2003). Simultaneous determination of four antipsychotic drugs in plasma by high-performance liquid chromatography. Journal of Chromatography B. 795(2). 257–264. 24 indexed citations
5.
Soukri, Mustapha, Saïd Lazar, María Dolors Pujol, et al.. (2003). Synthesis of new compounds containing the 2,3-dihydro[1,4]dioxino[2,3-b]pyridine heterocyclic system as a substructure. Tetrahedron. 59(20). 3665–3672. 11 indexed citations
6.
Matoga, Myriam, et al.. (2002). Determination of pKa values of 2-amino-2-oxazolines by capillary electrophoresis. Journal of Chromatography A. 984(2). 253–260. 32 indexed citations
7.
Péhourcq, Fabienne, et al.. (2002). Determination of mirtazapine and its demethyl metabolite in plasma by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B. 775(2). 163–168. 23 indexed citations
8.
Forfar, Isabelle, Fabienne Péhourcq, & C. Jarry. (2002). Rapid HPLC measurement of buflomedil in plasma in poisoning cases. Biomedical Chromatography. 16(7). 482–485. 4 indexed citations
9.
Matoga, Myriam, et al.. (2001). Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 760(2). 213–218. 45 indexed citations
10.
Péhourcq, Fabienne, C. Jarry, & B Bannwarth. (2001). Chiral resolution of flurbiprofen and ketoprofen enantiomers by HPLC on a glycopeptide‐type column chiral stationary phase. Biomedical Chromatography. 15(3). 217–222. 44 indexed citations
11.
Jarry, C., et al.. (2001). Synthesis and pharmacological evaluation of 5-dialkylaminomethyl-2-amino-2-oxazolines as H1-antagonists. Journal of Pharmacy and Pharmacology. 53(7). 923–927. 7 indexed citations
12.
13.
Jarry, C., et al.. (1999). Synthesis, Antitumour and Anti-HIV Screening of Oxazolidines and Oxazolidinones Derivatives. Pharmacy and Pharmacology Communications. 5(3). 211–215. 1 indexed citations
14.
Jarry, C., et al.. (1999). Structural and theoretical evidence of the reaction products of ethyl(ethoxymethylene)cyanoacetate with 5-phenoxymethyl-2-amino-2-oxazoline. Journal of Molecular Structure. 508(1-3). 193–205. 8 indexed citations
15.
Forfar, Isabelle, et al.. (1998). Kinetics of 5-(1-Phenyl-4-piperazinyl)methyl-2-amino-2-oxazoline Hydrolysis by High Performance Liquid Chromatography. Journal of Liquid Chromatography & Related Technologies. 21(9). 1379–1386.
16.
Jarry, C., et al.. (1996). INVESTIGATION OF THE REACTION OF PHENYLISOCYANATE WITH N-SUBSTITUTED 2-IMINOOXAZOLIDINES. Heterocyclic Communications. 2(4). 355–358. 1 indexed citations
17.
Jarry, C., et al.. (1995). Polymorphisme et chiralité de la N-phényl N’-[1-{3-(1 -phényl-4-pipérazino)propane-2-ol}]urée. Journal de Chimie Physique. 92. 1066–1083. 3 indexed citations
18.
Jarry, C., et al.. (1991). COR3224. Drugs of the Future. 16(10). 893–893. 10 indexed citations
19.
Demotes‐Mainard, F., et al.. (1991). RP-HPLC Retention Data of New 2-Amino-2-Oxazolines. An Approach of Their Lipophilic Properties. Journal of Liquid Chromatography. 14(4). 795–805. 12 indexed citations
20.
Butcher, R.N., Kenneth C. McCullough, C. Jarry, & Jennifer Bryant. (1988). Mitomycin C-treated cell feeder layers in hybridoma technology. Journal of Immunological Methods. 107(2). 245–251. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myriam Matoga Breakdown of academic impact, for papers by G.S. Murkitt Breakdown of academic impact, for papers by Tanja Alebić-Kolbah Breakdown of academic impact, for papers by Károly Mazák Breakdown of academic impact, for papers by Nafiz Öncü Can Breakdown of academic impact, for papers by A. Naidu Breakdown of academic impact, for papers by Bruce A. Lodge Breakdown of academic impact, for papers by Michael Chlenov Breakdown of academic impact, for papers by Kapendra Sahu Breakdown of academic impact, for papers by Alison L. Fisher
Rankless by CCL
2026